Baojie Wan

4.0k total citations
86 papers, 3.3k citations indexed

About

Baojie Wan is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Baojie Wan has authored 86 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 49 papers in Organic Chemistry and 47 papers in Infectious Diseases. Recurrent topics in Baojie Wan's work include Tuberculosis Research and Epidemiology (45 papers), Cancer therapeutics and mechanisms (36 papers) and Synthesis and biological activity (28 papers). Baojie Wan is often cited by papers focused on Tuberculosis Research and Epidemiology (45 papers), Cancer therapeutics and mechanisms (36 papers) and Synthesis and biological activity (28 papers). Baojie Wan collaborates with scholars based in United States, New Zealand and India. Baojie Wan's co-authors include Scott G. Franzblau, Alan P. Kozikowski, Yuehong Wang, Jialin Mao, Annamaria Lilienkampf, Yuehong Wang, Andrew M. Thompson, William A. Denny, Sang‐Hyun Cho and Zhenkun Ma and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Baojie Wan

86 papers receiving 3.3k citations

Peers

Countries citing papers authored by Baojie Wan

Since Specialization

Citations

This map shows the geographic impact of Baojie Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baojie Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baojie Wan more than expected).

Fields of papers citing papers by Baojie Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baojie Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baojie Wan. The network helps show where Baojie Wan may publish in the future.

Co-authorship network of co-authors of Baojie Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Baojie Wan. A scholar is included among the top collaborators of Baojie Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baojie Wan. Baojie Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of ultra short β-peptoids with selective activity against drug-resistant Mycobacterium tuberculosis 2025 ·European Journal of Medicinal Chemistry ·John F. Kauffman, José M. Cuevas, John Feiner, (unknown), Gauri Shetye, Baojie Wan, Mallique Qader, Nguyễn Minh Đức, A. G. Nugent, Anowar Hossain, Scott G. Franzblau, (unknown)	1
2	Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility 2021 ·ACS Medicinal Chemistry Letters ·Andrew M. Thompson, P. D. T. O’Connor, Vanessa Yardley, Louis Maes, Delphine Launay, Stéphanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper, William A. Denny	10
3	Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents 2019 ·ACS Medicinal Chemistry Letters ·(unknown), Baojie Wan, Yang Liu, Jiayi Shen, Scott G. Franzblau, Tianyu Zhang, Ke Ding, Xiaoyun Lu	17
4	Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes 2019 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Dirk Petersen, Louis Maes, An Matheeussen, (unknown), Anne Aamdal Scheie, Roger Simm, Rui Ma, Baojie Wan, Scott G. Franzblau, Lise‐Lotte Gundersen	9
5	Anti-Mycobacterium tuberculosis Activity of Esters of Quinoxaline 1,4-Di-N-Oxide 2018 ·Molecules ·(unknown), Julieta Luna‐Herrera, Edgar E. Lara‐Ramírez, (unknown), (unknown), Ma. Guadalupe Aguilera‐Arreola, Alma D. Paz-González, Antonio Monge, Baojie Wan, Scott G. Franzblau, Gildardo Rivera	14
6	Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity 2016 ·European Journal of Medicinal Chemistry ·Xiaoyun Lu, (unknown), (unknown), Baojie Wan, (unknown), Tianyu Zhang, Xiantao Zhang, Ke Ding	35
7	Anti-tuberculosis activity and structure–activity relationships of oxygenated tricyclic carbazole alkaloids and synthetic derivatives 2016 ·Bioorganic & Medicinal Chemistry ·Carsten Börger, (unknown), Konstanze K. Julich‐Gruner, Ronny Hesse, Vipan Kumar, (unknown), (unknown), (unknown), Baojie Wan, Scott G. Franzblau, Hans‐Joachim Knölker	33
8	Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 2015 ·European Journal of Medicinal Chemistry ·Marco Pieroni, Baojie Wan, Valentina Zuliani, Scott G. Franzblau, Gabriele Costantino, Mirko Rivara	16
9	Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase 2013 ·Bioorganic & Medicinal Chemistry ·Wei Lv, Biplab Banerjee, (unknown), Mohamed N. Seleem, (unknown), Maha I. Hamed, Baojie Wan, Scott G. Franzblau, Andrew D. Mesecar, Mark Cushman	31
10	Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models 2013 ·PLoS ONE ·Sean Ekins, Robert C. Reynolds, Scott G. Franzblau, Baojie Wan, Joel S. Freundlich, Barry A. Bunin	45
11	A novel indigoid anti-tuberculosis agent 2013 ·Bioorganic & Medicinal Chemistry Letters ·Larry L. Klein, (unknown), Baojie Wan, Yuehong Wang, (unknown), David C. Lankin, Guido F. Pauli, Scott G. Franzblau	9
12	Structure-Based Design of Novel Benzoxazinorifamycins with Potent Binding Affinity to Wild-Type and Rifampin-Resistant Mutant Mycobacterium tuberculosis RNA Polymerases 2012 ·Journal of Medicinal Chemistry ·(unknown), Hao Xu, Paul D. Kirchhoff, Tomasz Cierpicki, (unknown), Baojie Wan, Nan Zhang, (unknown), Scott G. Franzblau, George A. Garcia, Hollis D. Showalter	24
13	Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2 2012 ·European Journal of Medicinal Chemistry ·Xiaoyun Lu, Xiaobo Liu, Baojie Wan, Scott G. Franzblau, Lili Chen, Changlin Zhou, Qidong You	111
14	Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity 2011 ·European Journal of Medicinal Chemistry ·Kamaljit Singh, (unknown), Kawaljit Singh, Baojie Wan, Scott G. Franzblau, Kelly Chibale, Jan Balzarini	66
15	Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1 2011 ·European Journal of Medicinal Chemistry ·Xiaoyun Lu, Baojie Wan, Scott G. Franzblau, Qidong You	36
16	Synthesis and structure–activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Paul D. Kirchhoff, Baojie Wan, Scott G. Franzblau, George A. Garcia, Hollis D. Showalter	12
17	Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Colin Charnock, Baojie Wan, Scott G. Franzblau, (unknown)	22
18	5- tert -Butyl- N -pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[ d ]isoxazole-3-carboxamide Derivatives as Novel Potent Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase: Initiating a Quest for New Antitubercular Drugs 2008 ·Journal of Medicinal Chemistry ·Subash Velaparthi, Michael Brunsteiner, Reaz Uddin, Baojie Wan, Scott G. Franzblau, Pavel A. Petukhov	95
19	Structure–activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate synthase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jialin Mao, Hyungjin Eoh, Rong He, Yuehong Wang, Baojie Wan, Scott G. Franzblau, Dean C. Crick, Alan P. Kozikowski	35
20	Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents 2006 ·ChemMedChem ·Sarva Jayaprakash, Yasuyoshi Iso, Baojie Wan, Scott G. Franzblau, Alan P. Kozikowski	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact